인공요도괄약근 시술의 20년 경험 = Twenty Years of Experience with Artificial Urinary Sphincter Implantation

다국어 초록 (Multilingual Abstract)

Purpose: The efficacy of the artificial urinary sphincter(AUS) in treating sphincteric incontinence has been clearly demonstrated. We report on 20 years of experience using artificial sphincter implantation at a single institute.
Materials and Methods: The follow-up data for 37 patients who received AUS(AMS 800TM) implantation between 1987 and 2006 at Yonsei University were available for this study. We investigated various components of the medical records, such as the number of pads used per day, results of pre-operative urodynamic studies, operative and post-operative complications, and revision rate.
Results: Mean patient age was 35.6 years(range 15-64 years), and mean follow-up duration was 12.4 years(range 1.4-19.8 years). Of the 37 patients, 21 had neurogenic bladder, and 9 had traumatic injury. Other causes of incontinence included post-operative complications(4 patients) and congenital anomalies(3 patients). The cuffs were placed were in the bladder necks of 21 patients and in the bulbous urethrae of 16 patients. The average number of pads used daily decreased significantly from 6.2 to 1.2 after the operation, and 27 patients(72.9%) were able to maintain 'dry-up status' (number of pads used≤1). A total of 32 artificial sphincters remained in place(86.4% survival rate), with 8 revisions(21.6%) required secondary to infection, mechanical failure, or urethral stone.
Conclusions: AUS implantation is a safe and durable treatment for urinary incontinence in patients with intrinsic sphincter deficiency from various underlying diseases. (Korean J Urol 2008;49:520-525)

다국어 초록 (Multilingual Abstract)

Purpose: The efficacy of the artificial urinary sphincter(AUS) in treating sphincteric incontinence has been clearly demonstrated. We report on 20 years of experience using artificial sphincter implantation at a single institute.
Materials and Methods: The follow-up data for 37 patients who received AUS(AMS 800TM) implantation between 1987 and 2006 at Yonsei University were available for this study. We investigated various components of the medical records, such as the number of pads used per day, results of pre-operative urodynamic studies, operative and post-operative complications, and revision rate.
Results: Mean patient age was 35.6 years(range 15-64 years), and mean follow-up duration was 12.4 years(range 1.4-19.8 years). Of the 37 patients, 21 had neurogenic bladder, and 9 had traumatic injury. Other causes of incontinence included post-operative complications(4 patients) and congenital anomalies(3 patients). The cuffs were placed were in the bladder necks of 21 patients and in the bulbous urethrae of 16 patients. The average number of pads used daily decreased significantly from 6.2 to 1.2 after the operation, and 27 patients(72.9%) were able to maintain 'dry-up status' (number of pads used≤1). A total of 32 artificial sphincters remained in place(86.4% survival rate), with 8 revisions(21.6%) required secondary to infection, mechanical failure, or urethral stone.
Conclusions: AUS implantation is a safe and durable treatment for urinary incontinence in patients with intrinsic sphincter deficiency from various underlying diseases. (Korean J Urol 2008;49:520-525)

참고문헌 (Reference)

1 Scott FB, "Treatment of urinary incontinence by implantable prosthetic sphincter" 1 : 252-259, 1973

2 Westney OL, "Transurethral collagen injections for male intrinsic sphincter deficiency: the University of Texas-Houston experience" 174 : 994-997, 2005

3 Abrams P, "The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society" 61 : 37-49, 2003

4 Castle EP, "The male sling for post-prostatectomy incontinence: mean followup of 18 months" 173 : 1657-1660, 2005

5 Aaronson IA, "The AS 800 artificial urinary sphincter in children with myelodysplasia. Preliminary results" 69 : 686-688, 1986

6 Choo MS, "Prevalence of urinary incontinence in Korean women: an epidemiologic survey" 18 : 1309-1315, 2007

7 Montague DK, "Postprostatectomy urinary incontinence: the case for artificial urinary sphincter implantation" 55 : 2-4, 2000

8 Quek ML, "Long-term urodynamics followup of bladder augmentation for neurogenic bladder" 169 : 195-198, 2003

9 Gonzalez R, "Long-term results of the artificial urinary sphincter in male patients with neurogenic bladder" 154 : 769-770, 1995

10 Chartier-Kastler EJ, "Long-term results of augmentation cystoplasty in spinal cord injury patients" 38 : 490-494, 2000

11 Montague DK, "Long-term continence and patient satisfaction after artificial sphincter implantation for urinary incontinence after prostatectomy" 166 : 547-549, 2001

12 Light JK, "Long-term clinical results using the artificial urinary sphincter around bowel" 64 : 56-60, 1989

13 Chiaffarino F, "Impact of urinary incontinence and overactive bladder on quality of life" 43 : 535-538, 2003

14 Light JK, "Impact of the new cuff design on reliability of the AS800 artificial urinary sphincter" 147 : 609-611, 1992

15 Stone AR, "Evaluation and management of male urinary incontinence" 4(suppl 1) : 330-345, 2004

16 Wagner TH, "Economic costs of urinary incontinence in 1995" 51 : 355-361, 1998

17 Murray KH, "Detrusor behaviour following implantation of the Brantley Scott artificial urinary sphincter for neuropathic incontinence" 61 : 122-128, 1988

18 Petero VG Jr, "Comparison of the long-term outcomes between incontinent men and women treated with artificial urinary sphincter" 175 : 605-609, 2006

19 O'Connor RC, "Comparison of outcomes after single or DOUBLE-CUFF artificial urinary sphincter insertion" 62 : 723-726, 2003

20 Onur R, "Comparison of bone-anchored male sling and collagen implant for the treatment of male incontinence" 13 : 1207-1211, 2006

21 Chrouser KL, "Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup" 171 : 1152-1155, 2004

22 Furness PD 3rd, "Bladder augmentation: does it predispose to prosthetic infection of simultaneously placed artificial genitourinary sphincters or in situ ventriculoperitoneal shunts?" 84 : 25-29, 1999

23 Lopez Pereira P, "Artificial urinary sphincter: 11-year experience in adolescents with congenital neuropathic bladder" 50 : 1096-1101, 2006

24 Gousse AE, "Artificial urinary sphincter for post-radical prostatectomy urinary incontinence: long-term subjective results" 166 : 1755-1758, 2001

25 Light JK, "Alteration in detrusor behavior and the effect on renal function following insertion of the artificial urinary sphincter" 136 : 632-635, 1986

26 Moon YT, "A case of urinary incontinence treatment using AMS 800-artificial Sphincter" 27 : 337-344, 1986

27 Cho JS, "A case of urinary incontinence treated with AMS 800 artificial sphincter" 29 : 175-178, 1988

28 Ruiz E, "14 years of experience with the artificial urinary sphincter in children and adolescents without spina bifida" 176 : 1821-1825, 2006

29 Lai HH, "13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine" 177 : 1021-1025, 2007

30 Kang SJ, "10-year experience with artificial urethral sphincter" 38 : 192-197, 1997